Related Experiment Video

Updated: Apr 28, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.2K

[European Society of Cardiology guidelines on cardiac resynchronization therapy]

S Robinet, A Delcour, P Lancellotti

    Revue Medicale De Liege
    |June 14, 2014
    PubMed

    Insights

    Cardiac resynchronization therapy (CRT) is a successful heart failure treatment for over 25-30% of patients. This article reviews the 2013 European Society of Cardiology guidelines for CRT.

    Area of Science:

    • Cardiology
    • Heart Failure Management
    • Medical Device Therapy

    Context:

    • Cardiac resynchronization therapy (CRT) is a significant advancement in treating symptomatic heart failure.
    • Applicable to a substantial patient population (over 25-30%).
    • Builds upon established heart failure treatment paradigms.

    Purpose:

    • To summarize the 2013 European Society of Cardiology (ESC) recommendations for CRT.
    • To provide clinicians with updated guidance on CRT application.
    • To consolidate expert consensus on CRT in heart failure.

    Summary:

    • The article focuses on the 2013 European Society of Cardiology guidelines for cardiac resynchronization therapy.
    • It highlights CRT's role as a successful therapy for a significant portion of heart failure patients.
    • Key recommendations and indications for CRT are presented.

    Impact:

    • Facilitates optimal patient selection for CRT.
    • Aims to improve outcomes for heart failure patients undergoing CRT.
    • Supports evidence-based clinical decision-making in heart failure management.

    More Related Videos

    Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

    Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

    Published on: April 11, 2025

    2.3K
    A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair08:31

    A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

    Published on: October 16, 2021

    3.7K

    Related Concept Videos

    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    631
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    750
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    942
    Cardiopulmonary Resuscitation III: AED Use01:23

    Cardiopulmonary Resuscitation III: AED Use

    Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
    1.7K
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    788
    Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

    Cardiopulmonary Resuscitation IV: Pharmacological Management

    Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
    1.6K